LPL Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-36,827
| Closed | -$138K | – | 3338 |
|
|
2018
Q2 | $138K | Sell |
36,827
-16,339
| -31% | -$61.2K | ﹤0.01% | 3053 |
|
|
2018
Q1 | $217K | Buy |
53,166
+8,430
| +19% | +$34.4K | ﹤0.01% | 2879 |
|
|
2017
Q4 | $208K | Sell |
44,736
-2,866
| -6% | -$13.3K | ﹤0.01% | 2776 |
|
|
2017
Q3 | $338K | Buy |
47,602
+5,041
| +12% | +$35.8K | ﹤0.01% | 2257 |
|
|
2017
Q2 | $308K | Sell |
42,561
-6,259
| -13% | -$45.3K | ﹤0.01% | 2267 |
|
|
2017
Q1 | $282K | Buy |
48,820
+38,028
| +352% | +$220K | ﹤0.01% | 2242 |
|
|
2016
Q4 | $66K | Buy |
+10,792
| New | +$66K | ﹤0.01% | 2620 |
|
|
2016
Q2 | – | Sell |
-21,772
| Closed | -$102K | – | 3137 |
|
|
2016
Q1 | $102K | Sell |
21,772
-4,756
| -18% | -$22.3K | ﹤0.01% | 2942 |
|
|
2015
Q4 | $127K | Buy |
26,528
+8,319
| +46% | +$39.8K | ﹤0.01% | 2947 |
|
|
2015
Q3 | $59K | Sell |
18,209
-14,867
| -45% | -$48.2K | ﹤0.01% | 2706 |
|
|
2015
Q2 | $320K | Sell |
33,076
-4,502
| -12% | -$43.6K | ﹤0.01% | 2254 |
|
|
2015
Q1 | $465K | Buy |
37,578
+1,214
| +3% | +$15K | ﹤0.01% | 1901 |
|
|
2014
Q4 | $515K | Buy |
36,364
+4,670
| +15% | +$66.1K | ﹤0.01% | 1751 |
|
|
2014
Q3 | $456K | Buy |
31,694
+6,119
| +24% | +$88K | ﹤0.01% | 1864 |
|
|
2014
Q2 | $393K | Buy |
25,575
+707
| +3% | +$10.9K | ﹤0.01% | 1987 |
|
|
2014
Q1 | $424K | Buy |
24,868
+7,518
| +43% | +$128K | ﹤0.01% | 1861 |
|
|
2013
Q4 | $225K | Sell |
17,350
-4,700
| -21% | -$61K | ﹤0.01% | 2352 |
|
|
2013
Q3 | $199K | Buy |
22,050
+3,550
| +19% | +$32K | ﹤0.01% | 2325 |
|
|
2013
Q2 | $138K | Buy |
+18,500
| New | +$138K | ﹤0.01% | 2286 |
|